Search research articles
Contact Us
Filters
Showing results (171-180 of 219) with videos related to
Page
of 22
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2010
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors
George D Demetri, Margaret von Mehren, Cristina R Antonescu, et al.
Plos One
|
December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma
Jeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.
Nature Medicine
|
October 24, 2006
Genomic signatures to guide the use of chemotherapeutics
Anil Potti, Holly K Dressman, Andrea Bild, et al.
Annals of Surgical Oncology
|
August 12, 2024
Evolution of Initial Treatment for Desmoid Tumors
Alex J Bartholomew, Kristen E Rhodin, Laura Noteware, et al.
Nature Medicine
|
January 11, 2011
Retraction: Genomic signatures to guide the use of chemotherapeutics
Anil Potti, Holly K Dressman, Andrea Bild, et al.
Cancer Chemotherapy and Pharmacology
|
May 29, 2012
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
Gordana Vlahovic, Kellen L Meadows, Hope E Uronis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2024
Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial
Ravin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors
Ravin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2019
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Lara E Davis, Vanessa Bolejack, Christopher W Ryan, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 219) with videos related to
Sort By:
Page
of 22
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2010
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors
George D Demetri, Margaret von Mehren, Cristina R Antonescu, et al.
Plos One
|
December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma
Jeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.
Nature Medicine
|
October 24, 2006
Genomic signatures to guide the use of chemotherapeutics
Anil Potti, Holly K Dressman, Andrea Bild, et al.
Annals of Surgical Oncology
|
August 12, 2024
Evolution of Initial Treatment for Desmoid Tumors
Alex J Bartholomew, Kristen E Rhodin, Laura Noteware, et al.
Nature Medicine
|
January 11, 2011
Retraction: Genomic signatures to guide the use of chemotherapeutics
Anil Potti, Holly K Dressman, Andrea Bild, et al.
Cancer Chemotherapy and Pharmacology
|
May 29, 2012
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
Gordana Vlahovic, Kellen L Meadows, Hope E Uronis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2024
Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial
Ravin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors
Ravin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2019
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Lara E Davis, Vanessa Bolejack, Christopher W Ryan, et al.
Page
of 22